Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.（AQST）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aqst · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$9.00
+130.8% upside
Low
$6.00
Median: $9 · Last Close: $3.90
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$9.00
130.8% upside
High Target
$12
207.7%
Low Target
$6
53.8%
Current Price
$3.90
as of today
Based on analyst price targets, the AQST stock price prediction for the next 12 months ranges from $6 to $12. The consensus AQST price forecast of $9.00 implies 130.8% upside from the current price of $3.90.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.82 | ↓ 2.07% |
1-day model range: $3.79–$3.85. Peak: $3.85 (-2.07%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | +16.0% |
| 2028 | $5 | +26.2% |
| 2029 | $5 | +32.3% |
| 2030 | $5 | +35.9% |
| 2031 | — | +37.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AQST · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-09 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-09-08 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-06-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | Lake Street | Maintains | Buy→Buy |
| 2024-12-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aquestive Therapeutics, Inc. (AQST) stock. Of the recent 54 rating actions, 1 were upgrades and 0 were downgrades. 10 analysts currently cover AQST.
分析师推荐趋势
AQST analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$51M
↓ 49.8% YoY
Revenue Next Year
$70M
↑ 39.0% YoY
EPS This Year
$-0.42
EPS Next Year
$-0.44
↑ 5.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast AQST EPS of $-0.42 for the current fiscal year, based on estimates from 4 analysts. The AQST revenue forecast is $51M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AQST 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AQST 的共识目标价为 $9.00（+130.8% 上行空间），分析师共识为 Buy。
AQST 的短期预测（明日）为 $3.82（-2.07%）。 AQST 对 2027 年的股价预测均值为 $5。 AQST 对 2030 年的预测区间为 $5–$6。
Aquestive Therapeutics, Inc. 在 NASDAQ 上市，代码 AQST。AQST 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
AQST 预测 · 8 个问题根据 10 位华尔街分析师，AQST 的 12 个月平均目标价为 $9.00，最高 $12.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $3.90，隐含约 +130.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.